Correlations between family meals and psychosocial well-being among adolescents
ME Eisenberg, RE Olson… - … of pediatrics & …, 2004 - jamanetwork.com
Objective To determine the association between frequency of family meals and multiple
indicators of adolescent health and well-being (tobacco, alcohol, and marijuana use; academic …
indicators of adolescent health and well-being (tobacco, alcohol, and marijuana use; academic …
Intramyocardial Transplantation of Autologous CD34+ Stem Cells for Intractable Angina: A Phase I/IIa Double-Blind, Randomized Controlled Trial
…, K Story, V Zak, D Dowling, JH Traverse, RE Olson… - Circulation, 2007 - Am Heart Assoc
Background— A growing population of patients with coronary artery disease experiences
angina that is not amenable to revascularization and is refractory to medical therapy. …
angina that is not amenable to revascularization and is refractory to medical therapy. …
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure …
…, D Smith, L Westbrook, J Chen, E Handberg, RE Olson… - Jama, 2012 - jamanetwork.com
Context Previous studies using autologous bone marrow mononuclear cells (BMCs) in
patients with ischemic cardiomyopathy have demonstrated safety and suggested efficacy. …
patients with ischemic cardiomyopathy have demonstrated safety and suggested efficacy. …
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the …
…, JD Thomas, GV Silva, BC Jorgenson, RE Olson… - Jama, 2011 - jamanetwork.com
Context Clinical trial results suggest that intracoronary delivery of autologous bone marrow
mononuclear cells (BMCs) may improve left ventricular (LV) function when administered …
mononuclear cells (BMCs) may improve left ventricular (LV) function when administered …
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial
Context While the delivery of cell therapy after ST-segment elevation myocardial infarction (STEMI)
has been evaluated in previous clinical trials, the influence of the timing of cell …
has been evaluated in previous clinical trials, the influence of the timing of cell …
Long-term survival in patients with refractory angina
…, RF Garberich, BA Bart, RE Olson… - European heart …, 2013 - academic.oup.com
Aims An increasing number of patients with severe coronary artery disease (CAD) are not
candidates for traditional revascularization and experience angina in spite of excellent …
candidates for traditional revascularization and experience angina in spite of excellent …
Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation …
…, DH McKenna, K Harvey, BC Jorgenso, RE Olson… - American heart …, 2010 - Elsevier
BACKGROUND: Initial clinical trials from Europe have demonstrated that the administration
of bone marrow–derived mononuclear cells (BMCs) may improve left ventricular (LV) …
of bone marrow–derived mononuclear cells (BMCs) may improve left ventricular (LV) …
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers …
Rationale: Bone marrow (BM) cell therapy for ischemic heart disease (IHD) has shown
mixed results. Before the full potency of BM cell therapy can be realized, it is essential to …
mixed results. Before the full potency of BM cell therapy can be realized, it is essential to …
[HTML][HTML] LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow …
…, CR Cogle, S Baraniuk, RE Olson… - Texas Heart Institute …, 2010 - ncbi.nlm.nih.gov
A realistic goal for cardiac cell therapy may be to attenuate left ventricular remodeling following
acute myocardial infarction to prevent the development of congestive heart failure. Initial …
acute myocardial infarction to prevent the development of congestive heart failure. Initial …
Rationale and design for TIME: a phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone …
…, JR Forder, DA Taylor, CR Cogle, RE Olson… - American heart …, 2009 - Elsevier
Several previous studies have demonstrated that administration of autologous bone marrow–derived
mononuclear cells (BMMNCs) improves cardiac function in patients after acute …
mononuclear cells (BMMNCs) improves cardiac function in patients after acute …
